Abbott (ABT) Tops Q2 EPS by 1c, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $106.09 -2.07%
EPS Growth %: +9.2%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.2%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $6.64 billion versus the consensus estimate of $6.63 billion.
GUIDANCE:
Abbott sees FY2017 EPS of $2.43-$2.53, versus the consensus of $2.47.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Abbott wins FDA approval for dual-energy AFib ablation catheter
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
